{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:27:13Z","timestamp":1791354433385,"version":"4.3.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s00210-026-05004-6","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T03:36:01Z","timestamp":1769139361000},"page":"9727-9744","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Incorporation of network pharmacology, molecular docking, survival, density functional theory, and experimental studies to explore the potential key targets of formononetin by TERT-mediated anti-cancer effects in MCF-7 breast cancer"],"prefix":"10.1007","volume":"399","author":[{"given":"Rohit Singh","family":"Negi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit Kumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adarsh Kumar","family":"Pathak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh Kumar","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitish","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyotirmayee","family":"Behera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manjeet Kumar Sah","family":"Gond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand Kumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawan Kumar","family":"Dubey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil Kumar","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,23]]},"reference":[{"key":"5004_CR1","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-023-01996-w","volume":"40","author":"S Agrawal","year":"2023","unstructured":"Agrawal S, Das R, Singh AK, Kumar P, Shukla PK, Bhattacharya I, Tripathi AK, Mishra SK, Tiwari KN (2023) Network pharmacology-based anti-pancreatic cancer potential of kaempferol and catechin of Trema orientalis L. through computational approach. Med Oncol 40:133","journal-title":"Med Oncol"},{"key":"5004_CR2","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.breast.2022.08.010","volume":"66","author":"M Arnold","year":"2022","unstructured":"Arnold M, Morgan E, Rumgay H, Mafra A, Singh D, Laversanne M, Vignat J, Gralow JR, Cardoso F, Siesling S (2022) Current and future burden of breast cancer: global statistics for 2020 and 2040. Breast 66:15\u201323","journal-title":"Breast"},{"issue":"11","key":"5004_CR3","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.74362","volume":"16","author":"M Arshad","year":"2024","unstructured":"Arshad M et al (2024) Skin metastasis from solid tumors: Is targeted therapy making an impact? Cureus 16(11):e74362. https:\/\/doi.org\/10.7759\/cureus.74362","journal-title":"Cureus"},{"key":"5004_CR4","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1158\/1535-7163.MCT-06-0033","volume":"5","author":"MA Cerone","year":"2006","unstructured":"Cerone MA, Londo\u00f1o-Vallejo JA, Autexier C (2006) Telomerase inhibition enhances the response to anticancer drug treatment in human breast cancer cells. Mol Cancer Ther 5:1669\u20131675","journal-title":"Mol Cancer Ther"},{"key":"5004_CR5","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1159\/000356612","volume":"32","author":"J Chen","year":"2013","unstructured":"Chen J, Zhao X, Ye Y, Wang Y, Tian J (2013) Estrogen receptor beta-mediated proliferative inhibition and apoptosis in human breast cancer by calycosin and formononetin. Cell Physiol Biochem 32:1790\u20131797","journal-title":"Cell Physiol Biochem"},{"key":"5004_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1010171","volume":"18","author":"M Chinnam","year":"2022","unstructured":"Chinnam M, Xu C, Lama R, Zhang X, Cedeno CD, Wang Y, Stablewski AB, Goodrich DW, Wang X (2022) MDM2 E3 ligase activity is essential for p53 regulation and cell cycle integrity. PLoS Genet 18:e1010171","journal-title":"PLoS Genet"},{"key":"5004_CR7","doi-asserted-by":"publisher","first-page":"438","DOI":"10.3322\/caac.21583","volume":"69","author":"CE DeSantis","year":"2019","unstructured":"DeSantis CE, Ma J, Gaudet MM, Newman LA, Miller KD, Goding Sauer A, Jemal A, Siegel RL (2019) Breast cancer statistics, 2019. Ca-Cancer J Clin 69:438\u2013451","journal-title":"Ca-Cancer J Clin"},{"key":"5004_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.589929","volume":"11","author":"M Dratwa","year":"2020","unstructured":"Dratwa M, Wysocza\u0144ska B, \u0141acina P, Kubik T, Bogunia-Kubik K (2020) TERT\u2014regulation and roles in cancer formation. Front Immunol 11:589929","journal-title":"Front Immunol"},{"key":"5004_CR9","doi-asserted-by":"publisher","first-page":"3714","DOI":"10.1002\/cncr.32345","volume":"125","author":"D Dustin","year":"2019","unstructured":"Dustin D, Gu G, Fuqua SA (2019) ESR1 mutations in breast cancer. Cancer 125:3714\u20133728","journal-title":"Cancer"},{"key":"5004_CR10","doi-asserted-by":"publisher","first-page":"77540","DOI":"10.18632\/oncotarget.20560","volume":"8","author":"M Gay-Bellile","year":"2017","unstructured":"Gay-Bellile M, Veronese L, Combes P, Eymard-Pierre E, Kwiatkowski F, Dauplat M-M, Cayre A, Privat M, Abrial C, Bignon Y-J (2017) TERT promoter status and gene copy number gains: effect on TERT expression and association with prognosis in breast cancer. Oncotarget 8:77540","journal-title":"Oncotarget"},{"key":"5004_CR11","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3109\/10408363.2013.874403","volume":"51","author":"E Gocek","year":"2014","unstructured":"Gocek E, Moulas AN, Studzinski GP (2014) Non-receptor protein tyrosine kinases signaling pathways in normal and cancer cells. Crit Rev Clin Lab Sci 51:125\u2013137","journal-title":"Crit Rev Clin Lab Sci"},{"key":"5004_CR12","volume":"10","author":"RK Gupta","year":"2025","unstructured":"Gupta RK, Priyadarshan A, Tiwari S, Patel Y, Bind AK, Tripathi G, Tripathi A, Kumar A, Dubey PK (2025) THPM (1, 2, 3, 4-tetrahydro pyrimidine) and berberine exhibit synergistic impact on inhibition of cell migration and colonization through ROS-mediated apoptotic pathways in the breast cancer cells. ChemSelect 10:e202404148","journal-title":"ChemSelect"},{"key":"5004_CR13","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1053\/hupa.2002.124124","volume":"33","author":"MC Heinrich","year":"2002","unstructured":"Heinrich MC, Rubin BP, Longley BJ, Fletcher JA (2002) Biology and genetic aspects of gastrointestinal stromal tumors: KIT activation and cytogenetic alterations. Hum Pathol 33:484\u2013495","journal-title":"Hum Pathol"},{"key":"5004_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1023\/A:1006272527435","volume":"58","author":"SJ Hines","year":"1999","unstructured":"Hines SJ, Litz JS, Krystal GW (1999) Coexpression of c-kit and stem cell factor in breast cancer results in enhanced sensitivity to members of the EGF family of growth factors. Breast Cancer Res Treat 58:1\u201310","journal-title":"Breast Cancer Res Treat"},{"key":"5004_CR15","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/ng2006","volume":"39","author":"F Holst","year":"2007","unstructured":"Holst F, Stahl PR, Ruiz C, Hellwinkel O, Jehan Z, Wendland M, Lebeau A, Terracciano L, Al-Kuraya K, J\u00e4nicke F (2007) Estrogen receptor alpha (ESR1) gene amplification is frequent in breast cancer. Nat Genet 39:655\u2013660","journal-title":"Nat Genet"},{"key":"5004_CR16","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/nrclinonc.2015.117","volume":"12","author":"R Jeselsohn","year":"2015","unstructured":"Jeselsohn R, Buchwalter G, De Angelis C, Brown M, Schiff R (2015) ESR1 mutations\u2014a mechanism for acquired endocrine resistance in breast cancer. Nat Rev Clin Oncol 12:573\u2013583","journal-title":"Nat Rev Clin Oncol"},{"key":"5004_CR17","doi-asserted-by":"publisher","first-page":"12844","DOI":"10.3390\/ijms232112844","volume":"23","author":"E Judasz","year":"2022","unstructured":"Judasz E, Lisiak N, Kopczy\u0144ski P, Taube M, Rubi\u015b B (2022) The role of telomerase in breast cancer\u2019s response to therapy. Int J Mol Sci 23:12844","journal-title":"Int J Mol Sci"},{"key":"5004_CR18","doi-asserted-by":"publisher","first-page":"5049","DOI":"10.1158\/1078-0432.CCR-09-0632","volume":"15","author":"K Kalinsky","year":"2009","unstructured":"Kalinsky K, Jacks LM, Heguy A, Patil S, Drobnjak M, Bhanot UK, Hedvat CV, Traina TA, Solit D, Gerald W (2009) PIK3CA mutation associates with improved outcome in breast cancer. Clin Cancer Res 15:5049\u20135059","journal-title":"Clin Cancer Res"},{"key":"5004_CR19","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1038\/nrclinonc.2009.129","volume":"6","author":"LC Kim","year":"2009","unstructured":"Kim LC, Song L, Haura EB (2009) Src kinases as therapeutic targets for cancer. Nat Rev Clin Oncol 6:587\u2013595","journal-title":"Nat Rev Clin Oncol"},{"key":"5004_CR20","doi-asserted-by":"publisher","first-page":"8382","DOI":"10.3390\/ijms25158382","volume":"25","author":"NI Koufopoulos","year":"2024","unstructured":"Koufopoulos NI, Boutas I, Pouliakis A, Samaras MG, Kotanidis C, Kontogeorgi A, Dimas DT, Ieronimaki A-I, Leventakou D, Spathis A (2024) The \u201cforgotten\u201d subtypes of breast carcinoma: a systematic review of selected histological variants not included or not recognized as distinct entities in the current World Health Organization classification of breast tumors. Int J Mol Sci 25:8382","journal-title":"Int J Mol Sci"},{"key":"5004_CR21","doi-asserted-by":"publisher","first-page":"19072","DOI":"10.1038\/s41598-022-22059-6","volume":"12","author":"P Kumar","year":"2022","unstructured":"Kumar P, Singh AK, Tiwari KN, Mishra SK, Rajput VD, Minkina T, Cavalu S, Pop O (2022a) Identification and validation of core genes as promising diagnostic signature in hepatocellular carcinoma based on integrated bioinformatics approach. Sci Rep 12:19072","journal-title":"Sci Rep"},{"key":"5004_CR22","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-022-01759-z","volume":"39","author":"P Kumar","year":"2022","unstructured":"Kumar P, Singh AK, Verma P, Tiwari KN, Mishra SK (2022b) Network pharmacology-based study on apigenin present in the methanolic fraction of leaves extract of Cestrum nocturnum L. to uncover mechanism of action on hepatocellular carcinoma. Med Oncol 39:155","journal-title":"Med Oncol"},{"key":"5004_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2025.142768","volume":"1343","author":"P Kumari","year":"2025","unstructured":"Kumari P, Kumar P, Gupta RK, Tripathi A, Dubey PK, Ambasta A, Chauhan JK, Goura J, Kumar A, Tripathi G (2025) Synthesis, crystallographic study, in silico and in vitro investigation of novel flavonol-amino acid conjugate as an anti-proliferative agent. J Mol Struct 1343:142768","journal-title":"J Mol Struct"},{"key":"5004_CR24","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1038\/sj.onc.1208304","volume":"24","author":"JW Lee","year":"2005","unstructured":"Lee JW, Soung YH, Kim SY, Lee HW, Park WS, Nam SW, Kim SH, Lee JY, Yoo NJ, Lee SH (2005) PIK3CA gene is frequently mutated in breast carcinomas and hepatocellular carcinomas. Oncogene 24:1477\u20131480","journal-title":"Oncogene"},{"key":"5004_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/bcr2893","volume":"13","author":"L Lu","year":"2011","unstructured":"Lu L, Zhang C, Zhu G, Irwin M, Risch H, Menato G, Mitidieri M, Katsaros D, Yu H (2011) Telomerase expression and telomere length in breast cancer and their associations with adjuvant treatment and disease outcome. Breast Cancer Res 13:R56","journal-title":"Breast Cancer Res"},{"key":"5004_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13174287","volume":"13","author":"S \u0141ukasiewicz","year":"2021","unstructured":"\u0141ukasiewicz S, Czeczelewski M, Forma A, Baj J, Sitarz R, Stanis\u0142awek A (2021) Breast cancer\u2014epidemiology, risk factors, classification, prognostic markers, and current treatment strategies\u2014an updated review. Cancers (Basel) 13:4287","journal-title":"Cancers (Basel)"},{"key":"5004_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12112611","volume":"12","author":"J Lv","year":"2024","unstructured":"Lv J, Zhao X, Zhao L, Gong C, Zheng W, Guo L, Wang J, Liang T (2024) The notable role of telomere length maintenance in complex diseases. Biomedicines 12:2611","journal-title":"Biomedicines"},{"key":"5004_CR28","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.3390\/cancers11121826","volume":"11","author":"AE Maennling","year":"2019","unstructured":"Maennling AE, Tur MK, Niebert M, Klockenbring T, Zeppernick F, Gattenl\u00f6hner S, Meinhold-Heerlein I, Hussain AF (2019) Molecular targeting therapy against EGFR family in breast cancer: progress and future potentials. Cancers (Basel) 11:1826","journal-title":"Cancers (Basel)"},{"key":"5004_CR29","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.taap.2007.12.027","volume":"229","author":"SM Meeran","year":"2008","unstructured":"Meeran SM, Katiyar S, Katiyar SK (2008) Berberine-induced apoptosis in human prostate cancer cells is initiated by reactive oxygen species generation. Toxicol Appl Pharmacol 229:33\u201343","journal-title":"Toxicol Appl Pharmacol"},{"key":"5004_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/bcr3039","volume":"13","author":"TW Miller","year":"2011","unstructured":"Miller TW, Rexer BN, Garrett JT, Arteaga CL (2011) Mutations in the phosphatidylinositol 3-kinase pathway: role in tumor progression and therapeutic implications in breast cancer. Breast Cancer Res 13:224","journal-title":"Breast Cancer Res"},{"key":"5004_CR31","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.22825","volume":"8","author":"R Mishra","year":"2017","unstructured":"Mishra R, Hanker AB, Garrett JT (2017) Genomic alterations of ERBB receptors in cancer: clinical implications. Oncotarget 8:114371","journal-title":"Oncotarget"},{"key":"5004_CR32","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1038\/s41598-022-06384-4","volume":"12","author":"A Oda","year":"2022","unstructured":"Oda A, Inoue S, Kaneko R, Narita Y, Shiono S, Kaneko T, Tseng Y-C, Ohtani-Kaneko R (2022) Involvement of IGF-1R-PI3K-AKT-mTOR pathway in increased number of GnRH3 neurons during androgen-induced sex reversal of the brain in female tilapia. Sci Rep 12:2450","journal-title":"Sci Rep"},{"key":"5004_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110751","volume":"131","author":"V Pandey","year":"2020","unstructured":"Pandey V, Tripathi A, Rani A, Dubey PK (2020) Deoxyelephantopin, a novel naturally occurring phytochemical impairs growth, induces G2\/M arrest, ROS-mediated apoptosis and modulates lncRNA expression against uterine leiomyoma. Biomed Pharmacother 131:110751","journal-title":"Biomed Pharmacother"},{"key":"5004_CR34","doi-asserted-by":"publisher","first-page":"7377","DOI":"10.1002\/jcb.27041","volume":"119","author":"S Park","year":"2018","unstructured":"Park S, Bazer FW, Lim W, Song G (2018) The o-methylated isoflavone, formononetin, inhibits human ovarian cancer cell proliferation by sub G0\/G1 cell phase arrest through PI3K\/AKT and ERK1\/2 inactivation. J Cell Biochem 119:7377\u20137387","journal-title":"J Cell Biochem"},{"key":"5004_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2024.1474267","volume":"14","author":"EM Sabi","year":"2024","unstructured":"Sabi EM (2024) The role of genetic and epigenetic modifications as potential biomarkers in the diagnosis and prognosis of thyroid cancer. Front Oncol 14:1474267","journal-title":"Front Oncol"},{"issue":"6","key":"5004_CR36","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.semcancer.2011.10.001","volume":"21","author":"JW Shay","year":"2011","unstructured":"Shay JW, Wright WE (2011) Role of telomeres and telomerase in cancer. Semin Cancer Biol 21(6):349\u2013353. https:\/\/doi.org\/10.1016\/j.semcancer.2011.10.001","journal-title":"Seminars in cancer biology"},{"key":"5004_CR37","doi-asserted-by":"publisher","first-page":"13054","DOI":"10.3390\/ijms252313054","volume":"25","author":"M Shitova","year":"2024","unstructured":"Shitova M, Alpeeva E, Vorotelyak E (2024) Review of hTERT-immortalized cells: how to assess immortality and confirm identity. Int J Mol Sci 25:13054","journal-title":"Int J Mol Sci"},{"key":"5004_CR38","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1158\/1078-0432.CCR-0597-3","volume":"10","author":"R Simon","year":"2004","unstructured":"Simon R, Panussis S, Maurer R, Spichtin H, Glatz K, Tapia C, Mirlacher M, Rufle A, Torhorst J, Sauter G (2004) KIT (CD117)-positive breast cancers are infrequent and lack KIT gene mutations. Clin Cancer Res 10:178\u2013183","journal-title":"Clin Cancer Res"},{"key":"5004_CR39","doi-asserted-by":"publisher","first-page":"4447","DOI":"10.1007\/s12010-023-04363-7","volume":"195","author":"AK Singh","year":"2023","unstructured":"Singh AK, Kumar P, Rajput VD, Mishra SK, Tiwari KN, Singh AK, Minkina T, Pandey AK (2023) Phytochemicals, antioxidant, anti-inflammatory studies, and identification of bioactive compounds using GC\u2013MS of ethanolic novel polyherbal extract. Appl Biochem Biotechnol 195:4447\u20134468","journal-title":"Appl Biochem Biotechnol"},{"key":"5004_CR40","doi-asserted-by":"publisher","first-page":"6690","DOI":"10.1007\/s12010-024-04879-6","volume":"196","author":"AK Singh","year":"2024","unstructured":"Singh AK, Kumar P, Mishra SK, Rajput VD, Tiwari KN, Singh AK, Minkina T, Pandey AK, Upadhyay P (2024a) A dual therapeutic approach to diabetes mellitus via bioactive phytochemicals found in a poly herbal extract by restoration of favorable gut flora and related short-chain fatty acids. Appl Biochem Biotechnol 196:6690\u20136715","journal-title":"Appl Biochem Biotechnol"},{"key":"5004_CR41","doi-asserted-by":"publisher","first-page":"103138","DOI":"10.1016\/j.jksus.2024.103138","volume":"36","author":"AK Singh","year":"2024","unstructured":"Singh AK, Kumar P, Mishra SK, Tiwari K, Singh AK, Pandey AK, Shati AA, Alfaifi MY, Elbehairi SI, Sayyed R (2024b) A network pharmacology approach with experimental validation to discover protective mechanism of poly herbal extract on diabetes mellitus. J King Sauf Uni-Sci 36:103138","journal-title":"J King Sauf Uni-Sci"},{"key":"5004_CR42","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-024-02374-w","volume":"41","author":"K Singh","year":"2024","unstructured":"Singh K, Kumar P, Singh AK, Singh N, Singh S, Tiwari KN, Agrawal S, Das R, Singh A, Ram B (2024c) In silico and network pharmacology analysis of fucosterol: a potent anticancer bioactive compound against HCC. Med Oncol 41:130","journal-title":"Med Oncol"},{"key":"5004_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.molstruc.2024.141208","volume":"1327","author":"AK Singh","year":"2025","unstructured":"Singh AK, Kumar P, Gond MKS, Mishra SK, Tiwari KN, Singh AK (2025a) Berberine\u2019s antihyperglycemic effects via modulation of pancreatic ferroptosis and the CDC42-AR\/PTGS2\/ESR1 signaling pathway: a genomic and network pharmacology approach. J Mol Struct 1327:141208","journal-title":"J Mol Struct"},{"key":"5004_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2025.149652","author":"AK Singh","year":"2025","unstructured":"Singh AK, Pathak AK, Kumar P, Singh AK, Gond MKS, Negi RS, Das R, Agrawal S, Mishra SK, Tiwari KN (2025b) Effects of Asiatic acid on brain cancer by altering astrocytes and the AKT1-PRKCB signaling pathway: a genomic and network pharmacology perspective. Brain Res. https:\/\/doi.org\/10.1016\/j.brainres.2025.149652","journal-title":"Brain Res"},{"key":"5004_CR45","doi-asserted-by":"crossref","unstructured":"Sumathy H, Sangeetha J, Vijayalakshmi K (2011) Chromatographic fingerprint analysis of Ixora coccinea methanolic flower extract. Int J \u00a0Pharm Sci Drug Res, pp 327\u2013330","DOI":"10.25004\/IJPSDR.2011.030411"},{"key":"5004_CR46","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1186\/s12935-022-02678-9","volume":"22","author":"M Taheri","year":"2022","unstructured":"Taheri M, Ghafouri-Fard S, Najafi S, Kallenbach J, Keramatfar E, Atri Roozbahani G, Heidari Horestani M, Hussen BM, Baniahmad A (2022) Hormonal regulation of telomerase activity and hTERT expression in steroid-regulated tissues and cancer. Cancer Cell Int 22:258","journal-title":"Cancer Cell Int"},{"key":"5004_CR47","doi-asserted-by":"publisher","first-page":"820","DOI":"10.3389\/fphar.2019.00820","volume":"10","author":"K-C Tay","year":"2019","unstructured":"Tay K-C, Tan LT-H, Chan CK, Hong SL, Chan K-G, Yap WH, Pusparajah P, Lee L-H, Goh B-H (2019) Formononetin: a review of its anticancer potentials and mechanisms. Front Pharmacol 10:820","journal-title":"Front Pharmacol"},{"key":"5004_CR48","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1007\/s43450-023-00370-1","volume":"33","author":"AK Tripathi","year":"2023","unstructured":"Tripathi AK, Ray AK, Mishra SK, Bishen SM, Mishra H, Khurana A (2023) Molecular and therapeutic insights of alpha-lipoic acid as a potential molecule for disease prevention. Rev Bras Farmacogn 33:272\u2013287","journal-title":"Rev Bras Farmacogn"},{"key":"5004_CR49","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.3892\/ol.2020.11659","volume":"20","author":"T Trybek","year":"2020","unstructured":"Trybek T, Kowalik A, G\u00f3\u017ad\u017a S, Kowalska A (2020) Telomeres and telomerase in oncogenesis. Oncol Lett 20:1015\u20131027","journal-title":"Oncol Lett"},{"key":"5004_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-024-03624-7","volume":"24","author":"S Vahidi","year":"2024","unstructured":"Vahidi S, Zabeti Touchaei A (2024) Telomerase-based vaccines: a promising frontier in cancer immunotherapy. Cancer Cell Int 24:421","journal-title":"Cancer Cell Int"},{"key":"5004_CR51","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1016\/j.ejca.2008.05.019","volume":"44","author":"LS Velentzis","year":"2008","unstructured":"Velentzis LS, Woodside JV, Cantwell MM, Leathem AJ, Keshtgar MR (2008) Do phytoestrogens reduce the risk of breast cancer and breast cancer recurrence? What clinicians need to know. Eur J Cancer 44:1799\u20131806","journal-title":"Eur J Cancer"},{"key":"5004_CR52","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1016\/j.biopha.2018.09.033","volume":"109","author":"M Xin","year":"2019","unstructured":"Xin M, Wang Y, Ren Q, Guo Y (2019) Formononetin and metformin act synergistically to inhibit growth of MCF-7 breast cancer cells in vitro. Biomed Pharmacother 109:2084\u20132089","journal-title":"Biomed Pharmacother"},{"key":"5004_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-023-01244-8","volume":"21","author":"R Yang","year":"2023","unstructured":"Yang R, Han Y, Guan X, Hong Y, Meng J, Ding S, Long Q, Yi W (2023) Regulation and clinical potential of telomerase reverse transcriptase (TERT\/hTERT) in breast cancer. Cell Commun Signal 21:218","journal-title":"Cell Commun Signal"},{"key":"5004_CR54","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1093\/neuonc\/nox018","volume":"19","author":"\u00dc Yesil\u00f6z","year":"2017","unstructured":"Yesil\u00f6z \u00dc, Kirches E, Hartmann C, Scholz J, Kropf S, Sahm F, Nakamura M, Mawrin C (2017) Frequent AKT1 E17K mutations in skull base meningiomas are associated with mTOR and ERK1\/2 activation and reduced time to tumor recurrence. Neuro-Oncol 19:1088\u20131096","journal-title":"Neuro-Oncol"},{"key":"5004_CR55","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1007\/s00018-013-1376-3","volume":"71","author":"Z Zhou","year":"2014","unstructured":"Zhou Z, Qiao JX, Shetty A, Wu G, Huang Y, Davidson NE, Wan Y (2014) Retracted article: regulation of estrogen receptor signaling in breast carcinogenesis and breast cancer therapy. Cell Mol Life Sci 71:1549\u20131549","journal-title":"Cell Mol Life Sci"},{"key":"5004_CR56","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/9610629","volume":"2019","author":"Q Zhou","year":"2019","unstructured":"Zhou Q, Zhang W, Li T, Tang R, Li C, Yuan S, Fan D (2019) Formononetin enhances the tumoricidal effect of everolimus in breast cancer MDA-MB-468 cells by suppressing the mTOR pathway. Evid Based Complement Alternat Med 2019:9610629","journal-title":"Evid Based Complement Alternat Med"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05004-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05004-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05004-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T04:03:15Z","timestamp":1782100995000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-026-05004-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,23]]},"references-count":56,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["5004"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05004-6","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,23]]},"assertion":[{"value":"15 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No animals are involved.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"No human participants are involved.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}